Each therapy presents a different but effective treatment option.
Although the opioid epidemic is a broad societal problem, health systems can play a critical role in the response.
Members, as well as health plans, pharmacy benefit managers, plan sponsors, and reinsurers want to know how to fund these expensive treatments to ensure positive outcomes.
Topical niacinamide stabilizes the skin's outer barrier, reducing water loss and improving moisture levels in the epidermis.
Precision oncology represents an evolution in therapeutic practice.
Implementing these standards can be logistically challenging.
Data show these cases pose some of the most significant threats to patients and health systems.
With integrated specialty pharmacies enabling health systems to improve patient outcomes and lower total medical costs, every hospital will need a solution to support the growing number of patients on outpatient specialty medications.
Targeted therapies have greatly improved patient outcomes over the past 20 years.
It is the role of the pharmacist to ensure patients are adequately counseled on the adverse effects and potential harms of codeine.
The COVID-19 pandemic has created challenges and opportunities, and this requires agility and flexibility.
The COVID-19 pandemic highlighted the importance of managing infections properly globally and the need for stewardship networks among partners.
Vaccination provides an opportunity to prevent and treat herpes simplex virus infection.
32 public colleges with combined enrollment of more than 700,000 students must comply with law by January 2023.
Both indications for the CTLA-4 inhibitor were approved by the FDA in 2022.
Pharmacists are critically important in care delivery in their ability to influence patient success, patient-reported outcomes, and quality of life while reducing the burden on physicians and their clinical support teams.
Through recognizing the importance of research in the scope of pharmacy practice by national pharmacy organizations, research can become a prominent role and responsibility of pharmacy.
Lisa Nodzon, PhD, ARNP, AOCNP; Katie Tobon, PharmD, BCOP; and Javier Pinilla-Ibarz, MD, PhD, share insight on strategies for the monitoring and management of BTK inhibitor–associated toxicities in CLL and review the importance of a multidisciplinary approach to treatment.
RSV can exacerbate asthma development by causing damage to the tissue in the airways, promoting inflammation and increasing airway hyper-responsiveness
Methods of treating cervical intraepithelial neoplasia are limited and invasive. The need for better treatments is clear; however, there are several promising therapies under development.
Students are being exposed to new patient experiences through collaboration with practitioners.
Pharmacist-led discharge stewardship initiatives have shown promising results.
The researchers made a connection between positive outcomes for infectious disease patients, higher reimbursement class, and the presence of pharmacists in care teams.
Experts answer questions to help provide relief for those suffering with postnasal drip.
Sonidegib binds to and inhibits a transmembrane protein to disrupt hedgehog pathway signal transduction and leading to antitumor activity in patients with locally advanced basal cell carcinoma.
Microbubble cell separation can make next generation treatments, such as CAR T-cell therapy, more accessible.
This approach may help prevent premature deaths attributed to preventable or treatable cardiovascular disease.
Patient financial/co-pay assistance is usually a component of providing infusion services and practices need to make sure it’s carefully managed to prevent financial hardship to patients.